The report is based on primary data that was assessed and normalized against secondary information sources like published information and data sheets from companies, statistical data provided by trade associations and government agencies, industry publications, technical literature and trade journal articles.
Standard statistical and modeling techniques were used to derive projections and estimates of future market activities and market demand. Major topics covered under the report include an executive summary, diabetes economics, commercialization factors, design factors, and transdermal systems.
The market data presented in the report includes commercialization status of the noninvasive technology, assessments of technological risks, status analysis of noninvasive glucose monitor development, regulatory risk factors, market participants?? June 2008 provides an in-depth understanding of the capability and likelihood of impact on the diabetes care markets and outcomes of treatment by these noninvasive monitors to decision makers of life science companies, industry strategists, device designers, enabling technology providers, investors, healthcare administrators, and provider organization business managers.
The feature summary section of the report includes analysis and evaluation of noninvasive glucose monitoring and sensing technologies, products in development stage, assessment of market potential, and commercial opportunities and risks; examination of monitor design issues and emerging market factors; forecast on effect of the glucose sensing devices and technology on diabetes management markets and likely future developments, and evaluation of the effect of regulatory, technology, and economic factors on the commercial aspects of these monitors.
Glucose monitoring forms a regular life routine for diabetes patients. It is performed several-times-a day, which is crucial for the physiological health of these patients. The customary finger prick technique was used for decades as a standardized disease management tool. However, patient compliance issues, drawbacks of existing techniques to sense short-term glucose level fluctuations, have resulted in a search for more user-friendly and less invasive options.
Now the integration of state-of-the-art biocompatible product designs and small-scale electronics is promising an enhanced future for diabetes patients round the globe. The new monitors that can reliably and accurately measure the glucose levels can enhance patient well being and glycemic control. These monitors that integrate a power source, electronics, and the sensing element in a single package, are offering additional options for the healthcare staff and diabetes patients.
Enhancements in signal processing like better interference filtering and signal-to-noise ratios will be crucial to the noninvasive monitors??unto the market is intended to achieve two major goals namely: providing absolute relief to the numerous diabetes patients the world over and also igniting a revolution in the pharmaceutical industry such that in the next couple of years the corporate objectives of AD&K Pharmaceuticals Inc would have being achieved because the commanding heights of the industry will be reasonably under its control.
By : Harry Harris
Article From Exba Articles Directory